.Attribute Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view calls for addition of patients with MASLD and also size of liver outcomes in cardio-- kidney-- metabolic tests, when information recommend mechanistically possible perks and professional safety and security-- and details factors to consider for test style and regulatory commendation.